Scribe Biosciences: Funding, Investors & Team (Sep 2026)
Our fundamental technology, Printed Droplet Microfluidics (PDM), is a flexible and reconfigurable fluid handling system to perform picoliter-scale manipulations. By leveraging fluorescence-activated microfluidic droplet sorting and a specialized substrate, PDM enables the flexible and deterministic handling of single cells and fluid aliquots at extremely high throughputs.
Scribe Biosciences has raised $500k across 2 funding rounds on record, the most recent an undisclosed round announced in Jun 2023.
Scribe Biosciences Company Profile and Key Stats
Latest funding round on record: Jun 2023.
Scribe Biosciences Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Scribe Biosciences raised $500k in an undisclosed round announced in May 2021.
2.1 years later, an undisclosed round was announced in Jun 2023 with no disclosed amount.
Scribe Biosciences Founders and Leadership Team
Contact details for the Scribe Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Scribe Biosciences Funding Compared to Other Biotechnology Startups
Funded Startups Like Scribe Biosciences in Biotechnology and San Francisco
Companies Similar to Scribe Biosciences
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Scribe Biosciences Funding FAQs
What does Scribe Biosciences do?
Our fundamental technology, Printed Droplet Microfluidics (PDM), is a flexible and reconfigurable fluid handling system to perform picoliter-scale manipulations. By leveraging fluorescence-activated microfluidic droplet sorting and a specialized substrate, PDM enables the flexible and deterministic handling of single cells and fluid aliquots at extremely high throughputs.
How much funding has Scribe Biosciences raised?
Scribe Biosciences has raised $500k across 2 rounds on record.
When did Scribe Biosciences last raise funding?
Scribe Biosciences' most recent funding round on record was announced in Jun 2023. The amount was not disclosed.
Who founded Scribe Biosciences?
FundedIQ lists Russell Cole (Founder) at Scribe Biosciences.
Where is Scribe Biosciences headquartered?
Scribe Biosciences is based in San Francisco, California, United States.
How many employees does Scribe Biosciences have?
Scribe Biosciences is in the 1-10 employee band.
About FundedIQ's Scribe Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Scribe Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.